146 related articles for article (PubMed ID: 33960752)
21. Nonmelanoma skin cancer - from actinic keratosis to cutaneous squamous cell carcinoma.
Schmitz L; Oster-Schmidt C; Stockfleth E
J Dtsch Dermatol Ges; 2018 Aug; 16(8):1002-1013. PubMed ID: 30117703
[TBL] [Abstract][Full Text] [Related]
22. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
Stockfleth E; Kerl H; Zwingers T; Willers C
Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801
[TBL] [Abstract][Full Text] [Related]
23. Improvement of Actinic Keratoses Using Topical DNA Repair Enzymes: A Randomized Placebo-Controlled Trial.
Stoddard M; Herrmann J; Moy L; Moy R
J Drugs Dermatol; 2017 Oct; 16(10):1030-1034. PubMed ID: 29036257
[TBL] [Abstract][Full Text] [Related]
24. Clinical recognition of actinic keratoses in a high-risk population: how good are we?
Venna SS; Lee D; Stadecker MJ; Rogers GS
Arch Dermatol; 2005 Apr; 141(4):507-9. PubMed ID: 15837871
[TBL] [Abstract][Full Text] [Related]
25. Metabolomic Analysis of Actinic Keratosis and SCC Suggests a Grade-Independent Model of Squamous Cancerization.
Righi V; Reggiani C; Tarentini E; Mucci A; Paganelli A; Cesinaro AM; Mataca E; Kaleci S; Ferrari B; Meleti M; Magnoni C
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771721
[TBL] [Abstract][Full Text] [Related]
26. Topical kinase inhibitors induce regression of cutaneous squamous cell carcinoma.
Yang X; Daifallah AEM; Shankar S; Beer J; Marshall C; Dentchev T; Seykora F; D'Armas S; Hahn J; Lee V; Sabry HH; Farag AM; Seykora JT
Exp Dermatol; 2019 May; 28(5):609-613. PubMed ID: 30762245
[TBL] [Abstract][Full Text] [Related]
27. Differentiation between actinic keratoses and disseminated superficial actinic porokeratoses with reflectance confocal microscopy.
Ulrich M; Forschner T; Röwert-Huber J; González S; Stockfleth E; Sterry W; Astner S
Br J Dermatol; 2007 May; 156 Suppl 3():47-52. PubMed ID: 17488407
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Ingenol Mebutate in the Treatment of Actinic Keratoses: A Pre- and Posttreatment Dermoscopic Comparative Analysis.
Carbotti M; Coppola R; Zanframundo S; Devirgiliis V; Panasiti V
Biomed Res Int; 2018; 2018():4381019. PubMed ID: 30246021
[TBL] [Abstract][Full Text] [Related]
29. The clinical efficacy of topical methyl-aminolevulinate photodynamic therapy in moderate to severe actinic keratoses of the face and scalp.
Kleinpenning MM; van de Kerkhof PC; Gerritsen RM
J Dermatolog Treat; 2010 Jul; 21(4):252-7. PubMed ID: 19832288
[TBL] [Abstract][Full Text] [Related]
30. Actinic keratoses: past, present and future.
Fenske NA; Spencer J; Adam F
J Drugs Dermatol; 2010 May; 9(5 Suppl ODAC Conf Pt 1):s45-9. PubMed ID: 20518359
[TBL] [Abstract][Full Text] [Related]
31. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
[TBL] [Abstract][Full Text] [Related]
32. From actinic keratosis to squamous cell carcinoma: pathophysiology revisited.
Fernandez Figueras MT
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():5-7. PubMed ID: 28263020
[TBL] [Abstract][Full Text] [Related]
33. Actinic keratoses show variable histological basal growth patterns - a proposed classification adjustment.
Schmitz L; Gambichler T; Gupta G; Stücker M; Stockfleth E; Szeimies RM; Dirschka T
J Eur Acad Dermatol Venereol; 2018 May; 32(5):745-751. PubMed ID: 28796914
[TBL] [Abstract][Full Text] [Related]
34. Effect of Field Treatment of Actinic Keratosis With Ingenol Mebutate Gel on the Identification of Lesions for Biopsy.
Bettencourt MS
J Drugs Dermatol; 2015 Aug; 14(8):813-8. PubMed ID: 26267725
[TBL] [Abstract][Full Text] [Related]
35. Organ transplant status, anatomic location, and age impact rates of adnexal involvement of actinic keratoses.
McEwen MW; Tirado M; Lipman S; Patel T; Jones A
J Cutan Pathol; 2023 Jan; 50(1):62-65. PubMed ID: 36054580
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor receptor gene numerical aberrations are frequent events in actinic keratoses and invasive cutaneous squamous cell carcinomas.
Toll A; Salgado R; Yébenes M; Martín-Ezquerra G; Gilaberte M; Baró T; Solé F; Alameda F; Espinet B; Pujol RM
Exp Dermatol; 2010 Feb; 19(2):151-3. PubMed ID: 20156290
[TBL] [Abstract][Full Text] [Related]
37. Actinic keratoses: non-invasive diagnosis for field cancerisation.
Ulrich M; Maltusch A; Röwert-Huber J; González S; Sterry W; Stockfleth E; Astner S
Br J Dermatol; 2007 May; 156 Suppl 3():13-7. PubMed ID: 17488401
[TBL] [Abstract][Full Text] [Related]
38. Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses.
Dirschka T; Bierhoff E; Pflugfelder A; Garbe C
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):258-63. PubMed ID: 19709346
[TBL] [Abstract][Full Text] [Related]
39. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
Neittaanmäki-Perttu N; Karppinen TT; Grönroos M; Tani TT; Snellman E
Br J Dermatol; 2014 Nov; 171(5):1172-80. PubMed ID: 25109244
[TBL] [Abstract][Full Text] [Related]
40. Topical sulindac combined with hydrogen peroxide in the treatment of actinic keratoses.
Resnick L; Rabinovitz H; Binninger D; Marchetti M; Weissbach H
J Drugs Dermatol; 2009 Jan; 8(1):29-32. PubMed ID: 19180893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
